Evidence map›Paper›PMID 36318477›Full record

ArticleeLife2022

Regulated degradation of the inner nuclear membrane protein SUN2 maintains nuclear envelope architecture and function.

Logesvaran Krshnan, Wingyan Skyla Siu, Michael Van de Weijer, Daniel Hayward, Elena Navarro Guerrero, Ulrike Gruneberg, Pedro Carvalho

Open access · goldAbstract read
In one paragraph

Article in eLife, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
2.9field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 36 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Loss ofbioRxiv : the preprint server for biology · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Logesvaran KrshnanSir William Dunn School of Pathology, University of Oxford, Oxford, United Kingdom.ORCID 0000-0001-6281-1587
Wingyan Skyla SiuSir William Dunn School of Pathology, University of Oxford, Oxford, United Kingdom.
Michael Van de WeijerSir William Dunn School of Pathology, University of Oxford, Oxford, United Kingdom.ORCID 0000-0002-0954-0228
Daniel HaywardSir William Dunn School of Pathology, University of Oxford, Oxford, United Kingdom.
Elena Navarro GuerreroNuffield Department of Medicine, Target Discovery Institute, University of Oxford, Oxford, United Kingdom.
Ulrike GrunebergSir William Dunn School of Pathology, University of Oxford, Oxford, United Kingdom.
Pedro CarvalhoSir William Dunn School of Pathology, University of Oxford, Oxford, United Kingdom.ORCID 0000-0002-9691-5277
University of Oxford · GBTarget (United States) · US

Funding

Cancer Research UK DRCNPG-NOV21\100004Medical Research Council MR/K006703/1Wellcome TrustWellcome Trust 223153/Z/21/Z
6 · The paper itself

Abstract

Nuclear architecture and functions depend on dynamic interactions between nuclear components (such as chromatin) and inner nuclear membrane (INM) proteins. Mutations in INM proteins interfering with these interactions result in disease. However, mechanisms controlling the levels and turnover of INM proteins remain unknown. Here, we describe a mechanism of regulated degradation of the INM SUN domain-containing protein 2 (SUN2). We show that Casein Kinase 2 and the C-terminal domain Nuclear Envelope Phosphatase 1 (CTDNEP1) have opposing effects on SUN2 levels by regulating SUN2 binding to the ubiquitin ligase Skp/Cullin1/F-Box

Indexed as

beta-Transducin Repeat-Containing ProteinsNuclear EnvelopeCell NucleusMembrane ProteinsProteolysisUbiquitinbeta-Transducin Repeat-Containing ProteinsMembrane ProteinsUbiquitincell biologyendoplasmic reticulumERADhumannuclear envelopeprotein quality controlSUN2ubiquitin

Identifiers

PMID36318477
PMCPMC9662817
OpenAlexW4307793611

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.